Avantor (AVTR) vs Precipio (PRPO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Precipio (PRPO) has outperformed Avantor (AVTR) over the past year, gaining 25.5% versus a gain of 14.0%. Over five years, PRPO leads with a -54.1% price change compared with -60.0% for AVTR. Avantor is the larger company by market cap ($10.38 billion vs $42.1 million), about 246.6 times the size.
On valuation, Avantor trades at a lower forward P/E (17.5x vs 60.3x for Precipio).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVTR | PRPO |
|---|---|---|
| Share price | $15.35 | $23.52 |
| Market cap | $10.38B | $42.11M |
| 1-day change | -0.52% | +0.30% |
| YTD return | +33.94% | +2.35% |
| 1-year return | +13.96% | +25.47% |
| 5-year return | -59.97% | -54.06% |
| Forward P/E | 17.48 | 60.31 |
| EPS (TTM) | $-0.84 | $-0.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $6.55B | — |
| Revenue growth (YoY) | -3.41% | — |
| Net income (latest FY) | $-530.20M | — |
| Gross margin | 32.65% | — |
| Operating margin | -3.76% | — |
| Net margin | -8.09% | — |
| 52-week high | $16.38 | $33.63 |
| 52-week low | $7.27 | $16.40 |
| Distance from 52-week high | -6.26% | -30.06% |
| Analyst consensus | hold | — |
| Avg. price target upside | -3.71% | — |
| Average volume | 9.45M | 127.81K |
| Shares outstanding | 676.36M | 1.79M |
| Employees | 13,500 | — |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Avantor is about 246.6 times larger than Precipio by market value ($10.38B vs $42.11M).
- PRPO has outperformed AVTR by 11.5 percentage points over the past year.
About Avantor
AVTR stock →Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Industrials · Biotechnology: Laboratory Analytical Instruments · 13,500 employees
AVTR vs PRPO FAQ
Which is bigger, Avantor or Precipio?
Avantor (AVTR) is larger, with a market capitalization of $10.38B compared with $42.11M for Precipio (PRPO).
Which stock has performed better over the past year, AVTR or PRPO?
PRPO returned +25.47% over the past 12 months, compared with +13.96% for AVTR (price return, excluding dividends). Past performance does not predict future results.
Are Avantor and Precipio in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.